Evidence map›Paper›PMID 31523189›Full record

ArticleInternational journal of biological sciences2019

DGKζ Plays Crucial Roles in the Proliferation and Tumorigenicity of Human glioblastoma.

Xuefeng Gu, Guoqing Wan, Nianhong Chen, Jinhong Li, Bing Chen, Yeling Tang, Wangxian Gu, Cuiting Jin, Jihong Meng, Peng Zhang and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Xuefeng GuCollaborative Research Center, Shanghai University of Medicine & Health Sciences, Shanghai, PR China.
Guoqing WanCollaborative Research Center, Shanghai University of Medicine & Health Sciences, Shanghai, PR China.
Nianhong ChenCollaborative Research Center, Shanghai University of Medicine & Health Sciences, Shanghai, PR China.
Jinhong LiDepartment of Neurosurgery, Jiangmen Central Hospital, Jiangmen, Guangdong, PR China.
Bing ChenDepartment of Neurosurgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, PR China.
Yeling TangCollaborative Research Center, Shanghai University of Medicine & Health Sciences, Shanghai, PR China.
Wangxian GuCollaborative Research Center, Shanghai University of Medicine & Health Sciences, Shanghai, PR China.
Cuiting JinCollaborative Research Center, Shanghai University of Medicine & Health Sciences, Shanghai, PR China.
Jihong MengCollaborative Research Center, Shanghai University of Medicine & Health Sciences, Shanghai, PR China.
Peng ZhangCollege of Clinical Medicine, Shanghai University of Medicine & Health Sciences, Shanghai, PR China.
Li LiuCollege of Fundamental Medicine, Shanghai University of Medicine & Health Sciences, Shanghai, PR China.
Zhifang YangCollege of Fundamental Medicine, Shanghai University of Medicine & Health Sciences, Shanghai, PR China.
Changlian LuCollaborative Research Center, Shanghai University of Medicine & Health Sciences, Shanghai, PR China.
Shanghai University of Medicine and Health Sciences · CNGuangdong Medical College · CNJiangmen Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma is one of the most malignant brain cancers in adults, and it is a fatal disease because of its untimely pathogenetic location detection, infiltrative growth, and unfavorable prognosis. Unfortunately, multimodal treatment with maximal safe resection, chemotherapy and radiation has not increased the survival rate of patients with glioblastoma. Gene- and molecular-targeted therapy is considered to be a promising anticancer strategy for glioblastoma. The identification of novel potential targets in glioblastoma is of high importance. In this study, we found that both the mRNA and protein levels of diacylglycerol kinase ζ (DGKζ) were significantly higher in glioblastoma tissues than in precancerous lesions. The silencing of DGKζ by lentivirus-delivered shRNA reduced glioblastoma cell proliferation and induced G0/G1 phase arrest. Moreover, knockdown of DGKζ expression in U251 cells markedly reduced

Indexed as

AnimalsApoptosisBlotting, WesternBrain NeoplasmsCell CycleCell Line, TumorCell ProliferationDiacylglycerol KinaseFemaleFlow CytometryGene Expression Regulation, NeoplasticGlioblastomaGliomaHumansImmunohistochemistryMaleDGKZ protein, humanDiacylglycerol Kinasecell proliferationDiacylglycerol kinase zeta (DGKζ)glioblastomaphosphorylationtumorigenicity

Identifiers

PMID31523189
PMCPMC6743304
OpenAlexW3002357770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.